familymednews.com
Though hereditary hemorrhagic telangiectasia (HHT) is – as the name suggests – a hereditary disorder, most people are not diagnosed with the disease until they are adults because the telltale symptoms often do not develop until patients are in their late teens or early 20s. As a result, there is little data on the efficacy or value of the available […]
Continue reading »
While global rates of mental disorders in children have remained stable over time, the decline of infectious diseases will place mental disorders among the main causes of disease in children aged 4-15 years, according to a study published in the open access journal Child and Adolescent Psychiatry and Mental Health. Marie-Laure Baranne and Bruno Falissard at INSERM, France described the […]
Continue reading »
McLean Hospital and Harvard Medical School researchers believe they have uncovered a method that could be useful in predicting a depressed patient’s treatment prognosis, prior to starting treatment. In the paper “Pretreatment Rostral Anterior Cingulate Cortex Activity in Relation to Symptom Improvement in Depression: A Randomized Clinical Trial,” currently available online and scheduled to appear in the June 2018 edition […]
Continue reading »
For the first time, the history charting the world-renowned Avon Longitudinal Study of Parents and Children (ALSPAC), also known as Children of the ’90s, back to its beginnings has been made accessible. The work, made possible thanks to a Wellcome grant and a dedicated team of archivists from the University’s Special Collections, will mean that researchers can now access the […]
Continue reading »
Searching the entire genome, a Yale research team has identified a gene that when eliminated can spur regeneration of axons in nerve cells severed by spinal cord injury. “For the first time, the limits on nerve fiber regeneration were studied in an unbiased way across nearly all genes,” said Stephen Strittmatter, the Vincent Coates Professor of Neurology and senior author […]
Continue reading »
Researchers have discovered a new class of drug that has the potential to help cancer patients who no longer respond to existing therapies. The drug may not become available to patients for a number of years yet, but researchers believe that if clinical trials are successful, it could be used to tackle a variety of treatment-resistant cancers. Patients with breast […]
Continue reading »
Government and other scientists are proposing a new way to define Alzheimer’s disease—basing it on biological signs, such as brain changes, rather than memory loss and other symptoms of dementia that are used today. The move is aimed at improving research, by using more objective criteria like brain scans to pick patients for studies and enroll them sooner in the […]
Continue reading »
“Most people with a mild head injury take off work for a week and then forget about it, but some end up with long-term ailments like headaches,” says Lena Hoem Nordhaug, a PhD candidate in neuromedicine at the Norwegian University of Science and Technology (NTNU). She recently published her findings in the The Journal of Headache and Pain. Headaches became […]
Continue reading »
The sun’s radiation could be a factor in seasonal patterns of a deadly type of heart attack, according to new research that tracked a “summer shift” in their occurrence across seven countries. Previous research has examined how these attacks – called ST-elevation myocardial infarctions, or STEMIs – seem to happen most often in the daytime during the colder winter months, […]
Continue reading »
Sirolimus, which is used to prevent rejection after kidney transplants, has been used to successfully treat three cases of a rare disorder called diffuse idiopathic pulmonary neuroendocrine cell hyperplasia, or DIPNECH syndrome. The syndrome is so rare that there are no clinical recommendations to guide care and, therefore, no proven therapies. The brief case report is published in Annals of […]
Continue reading »